<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02036112</url>
  </required_header>
  <id_info>
    <org_study_id>IELAPE1127</org_study_id>
    <nct_id>NCT02036112</nct_id>
  </id_info>
  <brief_title>Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer</brief_title>
  <acronym>ELAPE</acronym>
  <official_title>Randomized Clinical Trial of Conventional Versus Individual Extralevator Abdominoperineal Excision for Locally Advanced Lower Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An alternative treatment for low rectal cancer is the extralevator abdominoperineal excision
      (ELAPE) technique. We aim to compare the outcomes of patients undergoing conventional ELAPE
      versus Individual ELAPE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We suppose that the ELAPE technique may be performed according to individual conditions. For
      the rectal tumors suitable for ELAPE, most of them were circular or nearly circular
      infiltrating tumors. Patients with these rectal tumors should receive full ELAPE resection.
      In those rectal tumors not involving the levator ani muscle, the dissection plane may
      continue close to the external anal sphincter and the levator ani muscle, leaving the
      ischioanal fat and the terminal branches of the pudendal nerve intact.If the tumor has only
      penetrated into 1 side of the levator ani muscle, the dissection might include the levator
      ani muscle and the fat of the ischioanal fossa on the side of the tumor to achieve a clear
      circumferential resection margin, whereas the ischioanal fat and levator ani muscle on the
      other side of the tumor may be left

      . This individual ELAPE may be as effective as conventional ELAPE while minimizing the
      operative trauma and the damage to the nerves of the genital organs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The perioperative morbidity</measure>
    <time_frame>three years</time_frame>
    <description>Sexual dysfunction,Urinary retention，Chronic perineal pain，Perineal wound infection，Urinary system infection，Pulmonary infection，Perineal seroma，Peristomal hernia，Abdominal wound infection，Perineal herniation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Three years survival postoperatively</measure>
    <time_frame>three years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Three years local recurrence postoperatively</measure>
    <time_frame>three years</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Individual ELAPE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive Individual ELAPE technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional ELAPE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with advanced lower rectal cancer will receive conventional EALPE technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional ELAPE</intervention_name>
    <description>device</description>
    <arm_group_label>Conventional ELAPE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Individual ELAPE</intervention_name>
    <description>device</description>
    <arm_group_label>Individual ELAPE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tumor within 5 cm of the anal verge or with a very narrow pelvis

          -  T3-T4 as determined by preoperative magnetic resonance imaging or endorectal
             ultrasonography examination or a low tumor is fixed or tethered at rectal examination

          -  Absence of distant metastases

          -  Absence of intestinal obstruction

        Exclusion Criteria:

          -  T1-T2 as determined by preoperative magnetic resonance imaging or endorectal
             ultrasonography examination

          -  With distant metastases

          -  With intestinal obstruction

          -  Pregnancy or lactation

          -  Allergic constitution to heterogeneous protein

          -  With operation contraindication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiagang Han, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jiagang Han, Professor</last_name>
    <phone>8613522867841</phone>
    <email>hjg211@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Chaoyang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiagang Han, Professor</last_name>
      <phone>8613522867841</phone>
      <email>hjg211@163.com</email>
    </contact>
    <investigator>
      <last_name>Jiagang Han, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/m/pubmed/22920402/</url>
  </link>
  <reference>
    <citation>Han JG, Wang ZJ, Wei GH, Gao ZG, Yang Y, Zhao BC. Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer. Am J Surg. 2012 Sep;204(3):274-82. doi: 10.1016/j.amjsurg.2012.05.001.</citation>
    <PMID>22920402</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>January 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2014</study_first_posted>
  <last_update_submitted>January 12, 2014</last_update_submitted>
  <last_update_submitted_qc>January 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Zhen Jun Wang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Advanced Lower rectal cancer</keyword>
  <keyword>Extralevator abdominoperineal excision</keyword>
  <keyword>Circumferential resection margin</keyword>
  <keyword>Morbidity</keyword>
  <keyword>Survival</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

